Tackling dengue fever: Current status and challenges

Area of Science:

• * Epidemiology and Public Health
• * Molecular Biology and Genetics
• * Infectious Diseases and Vaccinology

Background:

• * An estimated 96 million dengue infections occurred globally in 2010, exceeding WHO predictions.
• * The rapid spread of dengue fever presents a growing economic threat and a major challenge to healthcare systems.
• * Dengue poses a substantial global health burden, necessitating comprehensive understanding and intervention strategies.

Purpose of the Study:

• * To review the current epidemiological and clinical status of dengue fever.
• * To explore the connection between genetic mutations, single nucleotide polymorphism (SNP), and disease pathophysiology.
• * To highlight recent progress in dengue vaccine development.

Main Methods:

• * Literature review of epidemiological data and clinical studies on dengue.
• * Analysis of research on genetic factors, including SNPs, and their role in dengue pathogenesis.
• * Survey of recent advancements in dengue vaccine research and development.

Main Results:

• * Significant progress has been made in identifying dengue risk factors and understanding its molecular pathogenesis.
• * The relationship between genetic variations and dengue disease progression is an area of active investigation.
• * Several promising dengue vaccine candidates are in various stages of development.

Conclusions:

• * A deeper understanding of dengue's molecular features is crucial for improving treatments.
• * Development of robust animal models is essential for advancing therapeutic interventions.
• * Further research can lead to enhanced preventive measures for populations at risk of dengue infection.